Skip to content

SPAC Feed

Curated SPACs News

  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
  • News
Posted on November 6, 2024

S-4 – Semnur Pharmaceuticals, Inc. (0001584541) (Filer)

Filed: 2024-11-06 AccNo: 0001193125-24-251843 Size: 15 MB
Source: S-4 – Semnur Pharmaceuticals, Inc. (0001584541) (Filer)

By sf-admin

Post navigation

S-4 – Denali Capital Acquisition Corp. (0001913577) (Filer)
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali


  • About Us
  • Contact Us
  • Subscribe
Copyright © 2026 SPAC Feed. All Rights Reserved | News Vibe by Theme Palace